Back to Search
Start Over
A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel.
- Source :
-
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2016 Apr; Vol. 22 (2), pp. 219-27. Date of Electronic Publication: 2014 Nov 14. - Publication Year :
- 2016
-
Abstract
- Introduction: There is a paucity of data available to assess the occupational health and safety risk associated with exposure to monoclonal antibodies. Industry standards and published guidelines are conflicting or outdated. Guidelines offer contrary recommendations based on an array of methodological approaches. This survey aimed to describe current practices, beliefs and attitudes relating to the handling of monoclonal antibodies by Australian medical, nursing and pharmacy clinicians.<br />Methods: An electronic survey was distributed between June and September 2013. Respondents were surveyed on three focus areas: institutional guideline availability and content, current practices and attitudes. Demographic data relating to respondent and primary place of practice were also collected.<br />Results: A total of 222 clinicians completed the survey, with representation from all targeted professional groups and from a variety of geographic locations. 92% of respondents reported that their institution prepared or administered monoclonal antibodies, with 87% specifically handling anti-cancer monoclonal antibodies. Monoclonal antibodies were mostly prepared onsite (84-90%) and mostly within pharmacy clean-rooms (75%) and using cytotoxic cabinets (61%). 43% of respondents reported access to institutional monoclonal antibody handling guidelines with risk reduction strategies including training and education (71%), spill and waste management (71%), procedures for transportation (57%) and restricted handling (50%). Nurses had a stronger preference towards pharmacy manufacturing than both doctors and pharmacists for a range of clinical scenarios. 95% of all respondents identified that professional or regulatory body guidelines are an important resource when considering handling practices.<br />Conclusion: Monoclonal antibodies are most commonly handled according to cytotoxic drug standards and often in the absence of formal guidelines.<br /> (© The Author(s) 2014.)
- Subjects :
- Antineoplastic Agents adverse effects
Antineoplastic Agents standards
Chemistry, Pharmaceutical
Female
Humans
Male
Occupational Exposure prevention & control
Occupational Exposure standards
Occupational Health standards
Pharmacy methods
Protective Clothing
Antibodies, Monoclonal adverse effects
Nurses standards
Pharmacists standards
Pharmacy standards
Physicians standards
Surveys and Questionnaires
Subjects
Details
- Language :
- English
- ISSN :
- 1477-092X
- Volume :
- 22
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
- Publication Type :
- Academic Journal
- Accession number :
- 25398311
- Full Text :
- https://doi.org/10.1177/1078155214559113